Ascendis Pharma A/S

Biotechnology • Healthcare • Hellerup, Denmark • ASND (NMS)

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

45 70 22 22 44 Tuborg Boulevard 12, Denmark

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Here’s My Prediction For Who Could Acquire Ascendis Pharma (NASDAQ:ASND) - Seeking Alpha

Seeking Alpha • Dec 15

Rice Hall James & Associates LLC Trims Stock Holdings in Ascendis Pharma A/S $ASND - MarketBeat

MarketBeat • Dec 27

Assessing Ascendis Pharma (ASND)’s Valuation After a Strong 69.72% One-Year Shareholder Return - Yahoo Finance

Yahoo Finance • Dec 14

Stifel Analyst Boosts Ascendis Pharma Price Target Amid Strong Financial Performance - timothysykes.com

timothysykes.com • Dec 12

Ascendis Pharma Stock: Analyst Boosts Price Target Amid Sector Surge - StocksToTrade

StocksToTrade • Dec 12

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Ascendis Pharma A/S had layoffs?

No layoff events have been recorded for Ascendis Pharma A/S in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Ascendis Pharma A/S have?

Ascendis Pharma A/S has approximately 1,017 employees.

What industry is Ascendis Pharma A/S in?

Ascendis Pharma A/S operates in the Biotechnology industry, within the Healthcare sector.

Is Ascendis Pharma A/S a publicly traded company?

Yes, Ascendis Pharma A/S is publicly traded under the ticker symbol ASND on the NMS. The company has a market capitalization of approximately $12.89 billion.

Where is Ascendis Pharma A/S headquartered?

Ascendis Pharma A/S is headquartered in Hellerup, Denmark at Tuborg Boulevard 12, Denmark.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.